Best's Humanoid Robot Parts Business Still in Sample Phase
Best announced that its stock price experienced an abnormal fluctuation, with cumulative gains exceeding 30% over three consecutive trading days. The company noted significant market interest in hot concepts like humanoid robots. However, Best clarified that its business involving components for humanoid robots is currently in the sample stage. In the first half of 2026, revenue generated from these samples amounted to 223,000 yuan, representing approximately 0.03% of the company's total revenue. This indicates a very small scale for the business, which is not significantly impacting the company's overall performance. Furthermore, the future revenue from this segment carries substantial uncertainty.
The company's disclosure highlights a common dynamic where nascent technologies like humanoid robots attract speculative investor interest, leading to stock price volatility. Best's communication aims to temper expectations by emphasizing the early-stage nature of its involvement, with minimal current revenue contribution and significant future uncertainty. This situation underscores the inherent risks in investing in companies positioned within emerging technological sectors, where market hype can outpace tangible business development. Investors should carefully consider the long-term viability and scalability of such ventures beyond initial sample production and small-scale revenue streams, especially in the context of rapid technological advancements and evolving market demands over the next decade.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.